William Blair International Ldrs N holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
William Blair International Leaders Fund Class N Shares WILNX
- NAV / 1-Day Return 24.33 / −4.33 %
- Total Assets 1.2B
-
Adj. Expense Ratio
1.150%
- Expense Ratio 1.150%
- Distribution Fee Level High
- Share Class Type No Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.85%
- Turnover 91%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:14 AM GMT+0
Morningstar’s Analysis WILNX
Will WILNX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the WILNX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of WILNX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 34.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 5.48 | 63M | Technology |
SK Hynix Inc | 4.77 | 55M | Technology |
Samsung Electronics Co Ltd | 4.02 | 46M | Technology |
Fujikura Ltd | 3.30 | 38M | Industrials |
Accton Technology Corp | 3.12 | 36M | Technology |
Prysmian SpA | 2.78 | 32M | Industrials |
Hon Hai Precision Industry Co Ltd | 2.75 | 32M | Technology |
ASML Holding NV | 2.68 | 31M | Technology |
Astrazeneca | 2.61 | 30M | Healthcare |
Sumitomo Mitsui Financial Group Inc | 2.55 | 30M | Financial Services |
United States